Cargando…

Which GOLD B patients progress to GOLD D with the new classification?

BACKGROUND: The 2017 GOLD guidelines revised assessment of COPD by eliminating the FEV(1) criterion. AIM: First, we explored the redistribution of 2011 GOLD groups by reference to the 2017 GOLD criteria. Second, we investigated the characteristics of GOLD B patients and the natural course of GOLD B...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Hye Sook, Na, Ju Ock, Lee, Jong Deog, Shin, Kyeong-Cheol, Rhee, Chin Kook, Hwang, Yong Il, Lim, Seong Yong, Yoo, Kwang Ha, Jung, Ki Suck, Park, Yong Bum
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190819/ https://www.ncbi.nlm.nih.gov/pubmed/30349229 http://dx.doi.org/10.2147/COPD.S177944

Ejemplares similares

Comparison of Korean COPD Guideline and GOLD Initiative Report in Term of Acute Exacerbation: A Validation Study for Korean COPD Guideline
por: Hwang, Yong Il, et al.
Publicado: (2014)

Cut-off value of FEV(1)/FEV(6) to determine airflow limitation using handheld spirometry in subjects with risk of chronic obstructive pulmonary disease
por: Hwang, Yong Il, et al.
Publicado: (2021)

Clinical impacts of the classification by 2017 GOLD guideline comparing previous ones on outcomes of COPD in real-world cohorts
por: Song, Jin Hwa, et al.
Publicado: (2018)

Adherence to the GOLD Guideline in COPD Management of South Korea: Findings from KOCOSS Study 2011–2018
por: Kim, Tae-Ok, et al.
Publicado: (2019)

Racial Differences in Prevalence and Clinical Characteristics of Asthma–Chronic Obstructive Pulmonary Disease Overlap
por: Jo, Yong Suk, et al.
Publicado: (2021)

Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease
por: Shin, Sun Hye, et al.
Publicado: (2022)

Metabolic Syndrome in Early Chronic Obstructive Pulmonary Disease: Gender Differences and Impact on Exacerbation and Medical Costs
por: Choi, Hye Sook, et al.
Publicado: (2019)

Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients
por: Lim, Jeong Uk, et al.
Publicado: (2017)

Air Trapping and the Risk of COPD Exacerbation: Analysis From Prospective KOCOSS Cohort
por: Kim, Youlim, et al.
Publicado: (2022)

Chronic bronchitis is an independently associated factor for more symptom and high-risk groups
por: Choi, Joon Young, et al.
Publicado: (2016)

When is LABA/LAMA Better than LAMA in GOLD Group B or D Patients for Reducing Acute Exacerbations of COPD?
por: Shin, Hong-Joon, et al.
Publicado: (2023)

Prevalence, characteristics, and risk of exacerbation in young patients with chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2022)

Ambulatory oxygen therapy with documented self-monitoring of oxygen use improves health status among patients with chronic obstructive pulmonary disease
por: Kim, Youlim, et al.
Publicado: (2022)

Active case finding strategy for chronic obstructive pulmonary disease with handheld spirometry
por: Kim, Joo Kyung, et al.
Publicado: (2016)

Reliability of Portable Spirometry Performed in the Korea National Health and Nutrition Examination Survey Compared to Conventional Spirometry
por: Park, Hye Jung, et al.
Publicado: (2021)

Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD
por: Rhee, Chin Kook, et al.
Publicado: (2015)

Natural course of early COPD
por: Rhee, Chin Kook, et al.
Publicado: (2017)

Clinical Characteristics and Changes of Clinical Features in Patients with Asthma-COPD Overlap in Korea according to Different Diagnostic Criteria
por: Lim, Jeong Uk, et al.
Publicado: (2020)

The health-related quality-of-life of chronic obstructive pulmonary disease patients and disease-related indirect burdens
por: Choi, Hye Sook, et al.
Publicado: (2020)

Recent Prevalence of and Factors Associated With Chronic Obstructive Pulmonary Disease in a Rapidly Aging Society: Korea National Health and Nutrition Examination Survey 2015–2019
por: Kim, Sang Hyuk, et al.
Publicado: (2023)

Differences in prevalence of asthma–COPD overlap according to different criteria
por: Song, Jin Hwa, et al.
Publicado: (2018)

Relationship Between Changes in Inhalation Treatment Level and Exacerbation of Chronic Obstructive Pulmonary Disease: Nationwide the Health Insurance and Assessment Service Database
por: Jo, Yong Suk, et al.
Publicado: (2020)

Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease
por: Lee, Jung-Kyu, et al.
Publicado: (2019)

Strategies for Management of the Early Chronic Obstructive Lung Disease
por: Lee, Jung Yeon, et al.
Publicado: (2016)

Effect of low protein intake on acute exacerbations in mild to moderate chronic obstructive pulmonary disease: data from the 2007–2012 KNHANES
por: Park, Sojung, et al.
Publicado: (2021)

Different Pattern of Chronic Obstructive Pulmonary Disease Assessment Test Score between Chronic Bronchitis and Non-chronic Bronchitis Patients
por: Yoo, Sang Hoon, et al.
Publicado: (2018)

Male current smokers have low awareness and optimistic bias about COPD: field survey results about COPD in Korea
por: Hwang, Yong Il, et al.
Publicado: (2019)

Which bronchodilator reversibility criteria can predict severe acute exacerbation in chronic obstructive pulmonary disease patients?
por: Kim, Junghyun, et al.
Publicado: (2017)

Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea (CITRUS) Study
por: Lee, Ye Jin, et al.
Publicado: (2021)

The Long-term Efficacy of Domiciliary Noninvasive Positive-Pressure Ventilation in Chronic Obstructive Pulmonary Disease: A Meta-Analysis of Randomized Controlled Trials
por: Park, So Young, et al.
Publicado: (2022)

Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2020)

Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort
por: Lee, Jung Yeon, et al.
Publicado: (2016)

Longitudinal changes in forced expiratory volume in 1 s in patients with eosinophilic chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2022)

Impact of BMI on exacerbation and medical care expenses in subjects with mild to moderate airflow obstruction
por: Jo, Yong Suk, et al.
Publicado: (2018)

The Impact of Inhaled Corticosteroids on the Prognosis of Chronic Obstructive Pulmonary Disease
por: Park, Ji Won, et al.
Publicado: (2023)

Identification of subtypes in subjects with mild-to-moderate airflow limitation and its clinical and socioeconomic implications
por: Lee, Jin Hwa, et al.
Publicado: (2017)

Definitions of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Exacerbation: A Modified Delphi Survey
por: Park, Yong Bum, et al.
Publicado: (2023)

FVC, but not FEV(1,) is associated with clinical outcomes of asthma-COPD overlap
por: An, Tai Joon, et al.
Publicado: (2022)

Effect of Broncho-Vaxom (OM-85) on the frequency of chronic obstructive pulmonary disease (COPD) exacerbations
por: Choi, Joon Young, et al.
Publicado: (2023)

Korean Asthma Guideline 2014: Summary of Major Updates to the Korean Asthma Guideline 2014
por: Kim, Deog Kyeom, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l9vo3fl73nenm3mgavcs35f5oa